XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2010-01395
- Event Type
- Injury
- Date Received
- July 14, 2010
- Date of Event
- May 10, 2010
- Report Date
- June 19, 2010
- Manufacturer
- ABBOTT VASCULAR-CARDIAC THERAPIES
- Product Code
- NIQ
- PMA / PMN Number
- P070015
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
(B) (4). THE STENT REMAINS IN THE PT. A F/U WILL BE SUBMITTED WITH ALL RELEVANT INFO. THE ALLSTAR (PART UNK, LOT UNK), INDICATED, IS BEING FILED UNDER A SEPARATE MFR #.
INTERNAL FILE NUMBER - (B)(4). ADDITIONAL INFORMATION RECEIVED FROM THE ACCOUNT ON 7/29/2010, REVEALED THAT THE REPORTED MYOCARDIAL INFARCTION WAS DETERMINED TO BE DUE TO THE NON-TARGET OBTUSE MARGINAL ARTERY AND THE THREE INDEX XIENCE V STENTS WERE PATENT PER THE ANGIOGRAM IN (B)(6) 2010. THEREFORE, THIS COMPLAINT SHOULD NOT HAVE BEEN FILED AGAINST THIS INDEX. XIENCE V STENT; HOWEVER, SINCE A MEDICAL DEVICE REPORT (MDR) HAS ALREADY BEEN FILED, THIS EVENT MUST REMAIN A COMPLAINT AND MDR REPORTABLE.
DEVICE ISSUE: NONE. ADVERSE EVENT: MI REQUIRING INTERVENTION. ONSET OF ADVERSE EVENT: AFTER THE PROCEDURE. IT WAS REPORTED VIA TRIAL THAT ON (B) (6)2007, THE PT UNDERWENT STENTING IN THE PREDILATED MID RIGHT CORONARY ARTERY (RCA) WITH TWO XIENCE V STENTS AND IN THE PREDILATED PROXIMAL LEFT ANTERIOR DESCENDING ARTERY WITH ONE XIENCE V STENT. THE SECOND RCA XIENCE V STENT WAS IMPLANTED FOR TREATMENT OF A DISSECTION DISTAL TO THE TARGET LESION THAT WAS IDENTIFIED AFTER POST DILATATION, CAUSED BY AN ALLSTAR GUIDEWIRE. ON (B) (6)2010, THE PT BEGAN EXPERIENCING ANGINA, WAS ADMITTED TO THE HOSPITAL ON (B) (6)2010, AND DIAGNOSED WITH A NON Q-WAVE MYOCARDIAL INFARCTION. THE PT UNDERWENT DIAGNOSTIC CORONARY ANGIOGRAPHY WHICH REVEALED TOTAL OCCLUSION OF THE OBTUSE MARGINAL DUE TO THROMBUS, AND A 90% LESION IN THE MID RCA GREATER THAN 5 MM FROM THE INDEX STENT. REVASCULARIZATION WAS PERFORMED ON (B) (6)2010, VIA BALLOON ANGIOPLASTY AND IMPLANTATION OF A BARE METAL STENT IN THE MID RCA. THE PT'S CONDITION RESOLVED WITHOUT SEQUELA ON (B) (6)2010. THERE WAS NO ADD'L INFO PROVIDED.
SUBSEQUENT TO THE PREVIOUS MEDWATCH REPORT, ADDITIONAL INFORMATION INDICATED THAT AN ANGIOGRAM DONE IN (B)(6) 2010, FOUND THAT THE THREE INDEX XIENCE STENTS WERE PATENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM | NIQ | ABBOTT VASCULAR-CARDIAC THERAPIES | NA | 60601P1 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Male | Hospitalization| S| R | GUIDE WIRE: ALLSTAR (PART UNK, LOT)| STENT: XIENCE V (X2)| GUIDE WIRE: ALLSTAR (PART UNK, LOT)| STENT: XIENCE V (X2) |